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1 INTRODUCTION 
1.1 Research area 
In this global market, the world has shifted to a more complex and fast-paced economic 
environment where every small advantage and improvement can translate into success. 
In the grand scheme of things, even the government institutions, such as hospitals and 
bureaus, need to adapt to the ever-changing world and start focusing improving opera-
tional environments. Information systems in medical institutions have been a highly 
discussed topic in Finland for the past 30 years. Ever since the launch of the controver-
sial Apotti-project, a new centralized customer- and patient information system for mu-
nicipalities around the metropolis Helsinki area, media has been raising questions about 
legacy information systems in hospitals. Although in the case of Apotti-project the cost 
of the new system has been the main talking point, there are other factors in the current 
information systems that require attention. Chen et al. (2013) claim that IT adaptation in 
health sector at an international level drags 10 to 15 years behind other industries.  The 
main concerns regarding these old systems seem to revolve around the costs which 
these old systems create. For example, Savon Sanomat reported in September 2013 that 
in University hospital of Kuopio alone there was 300 000 euros worth of waste in medi-
cines. The main reason for waste in medicine, according to apothecary Toivo Naaralahti 
in Kuopio University hospital, is expiration (Savonsanomat.fi, 2013). On a larger scale, 
Turun Sanomat (2016) reported that on national level in Finland, the medical waste 
amounted to over 6.3 million euros.  
In order to understand what is causing the waste in hospitals, one has to examine the 
supply chain networks and the information systems that are used in the procurement 
processes.  Of course, there are many other things to consider when discussing the rea-
sons for waste in hospitals. One example would be legislative requirements for safety 
stock of medicines which require hospitals to have a certain amount of medicine availa-
ble at any given moment (finlex.fi, 2008). These requirements lead to inevitable waste 
in certain medicines which have short expiration period. However, this alone is not 
enough to explain the amount of waste that is created in hospitals. As the information 
systems in hospitals are getting more and more outdated, there is reason to believe that 
with better information systems and procurement processes there would be huge im-
provements in efficiency and hence cost savings. 
At the moment, there are multiple different modernization projects in hospitals all 
over Finland. This gives us a great opportunity to examine their current information 
systems and their capabilities in the modern practice of medicine. Are the information 
systems up to date? Are there possibilities to simplify the supply chain networks and 
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consolidate the information systems involved in the procurement processes in order to 
remove waste? 
1.2 Research gap 
There has not been much current research done on the procurement processes in hospi-
tals and information systems involved in aforementioned processes. De Vries and 
Huijsman (2011) see our knowledge and understanding of the health care sector, from 
the perspective of supply chain management, to be vastly fragmented. Moreover, they 
note the importance of further examining the role of information technology in support-
ing management and control of supply chain activities. It has been previously acknowl-
edged that there are inefficiencies in hospitals, which create waste. The goal of this the-
sis is to better understand the procurement processes of medical supplies and medicines 
in university hospitals and to find out whether there are common patterns and proce-
dures, which contribute towards generation of medical waste. The thesis also aims to 
determine best practices in processes and information systems relying on the literature 
reviewed. Furthermore, the future possibilities to enhance the current integrations in 
hospital procurement processes and information systems are explored. 
1.3 Research questions 
The research questions seek to guide this study into medical waste. In order to under-
stand the root causes and focal points in the upstream pharmaceutical supply chain, this 
study attempts to answer the following questions: 
 
(1) What are the best practices in medical supply chain management and how ap-
propriate information systems can further enhance the procurement process? 
(2) What is the current state of pharmaceutical procurement processes and infor-
mation systems in Turku University hospital? 
(3) What are the future prospects of integration in hospital procurement processes 
and information systems? 
 
To find answers to the aforementioned questions, first an extensive literature review 
will be performed in order to establish the best practices relying on scientific literature. 
After this, interviews with medical professionals working in the hospital pharmacy will 
be conducted. Finally, the results of the interviews will be combined and thoroughly 
analyzed. Based on the comprehensive analysis, conclusions will be made. 
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1.4 Scope of the study 
The scope of this study are the processes and procurement information systems used in 
Turku University hospital. This university hospital was chosen because it represents the 
state-of-the-art hospital in Finland and is prominent in modernization. The University 
hospital of Turku will be introduced further on. 
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2 LITERATURE REVIEW 
This literature review will concentrate on different ways to set up, control and improve 
organization’s logistics, more specifically inbound logistics in University hospitals. 
While Supply Chain Management presents a comprehensive philosophy on how to 
manage all aspects of logistics, Just-In-Time logistics (JIT), Vendor Managed Inventory 
(VMI) and Collaboration in Forecasting, Planning and Replenishment (CFPR) offer 
more specific alternatives. In this chapter we will go through the characteristics of these 
different models.  
2.1 Supply chain management 
Menzer et al. (2001) acknowledge that in research the term supply chain management 
can be defined very differently depending on the context. Jones and Riley (1985) define 
supply chain management to “deal with the total flow of materials from suppliers 
through end users…”. On the other hand, Cooper et al. (1997) elaborates on the defini-
tion and describes supply chain management to be “…an interactive philosophy to man-
age the total flow of distribution channel from supplier to the ultimate user.” Moreover, 
Harland (1996) recognizes four main meanings for supply chain management: 
• The internal supply chain that integrates business functions involved in the 
flow of materials and information from inbound to outbound ends of busi-
ness. 
• The management of dyadic or two-party relationships with immediate suppli-
ers. 
• The management of a chain of businesses including suppliers, supplier’s sup-
pliers, customers and customer’s customers and so on. 
• The management of a network of interconnected businesses involved in the 
ultimate provision of product and service packages required by end customer. 
Although supply chain management seems to create discussion among the academ-
ics, the definition of supply chain has been more commonly agreed upon. Menzer et al. 
(2001) define supply chain to be “a set of three or more entities (organizations or indi-
viduals) directly involved in the upstream and downstream flows of products, services, 
finances and/or information from a source to the customer.” In addition, even though 
the point of views may differ, the main issues in supply chain management are more 
universally accepted to be elimination of waste and performance improvements by co-
ordinating supply chains (de Vries and Huijsman, 2011). De Vries and Huijsman (2011) 
also suggest that the health care sector lags behind the manufacturing industry sector in 
adapting the methods and practices of supply chain management. This thesis concen-
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trates on the upstream flows of a hospital supply chain. Upstream flows in the context 
of hospital supply chain refer to the logistical activities that occur outside the hospital. 
For example activities between the pharmaceutical wholesaler and the hospital pharma-
cy. More specifically, this study focuses in the procurement of pharmaceuticals; the 
processes involved in procurement and the information systems that are being used in 
the process. Supply chain management practices in the health care sector are evaluated, 
by industry experts, to be roughly 10 years behind retail and manufacturing industries 
(Chen et al. 2013).  
2.1.1 Supply chain 
Supply chain is in the center of supply chain management and in order to understand 
supply chain management, we must understand what a supply chain is. Supply chain 
can also often be described as distribution channels. On its most basic level, a supply 
chain can be viewed as a three-player chain of material and information flows consist-
ing of supplier, organization and customer.  Figure 1 illustrates a direct supply chain 
and the material and information flows within it. The ellipses represent the parties with-
in the supply chain and the arrows depict the information and material flows. (Mentzer 
et al. 2001) 
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Figure 1 Different modes of supply chains (adapted from Mentzer et al. 
2001) 
The first supply chain pictured in Figure 1 can be found from the upstream or down-
stream of material and information flows. Thomas and Griffin (1996) determine supply 
chain to have traditionally three different stages: procurement, production and distribu-
tion. In Figure 1, the procurement occurs from supplier to organization. The organiza-
tion then produces the product and then distributes it to its customers. This is a very 
simplified view of the supply chain and Mentzer et al. (2001) also present a second, 
more complex level of supply chains, an extended supply chain. In the extended supply 
chain, shown in Figure 1, the suppliers have suppliers and customers have customers. 
Although the extended supply chain presented in Figure 1 gives a better understand-
ing of supply chains in reality, it is still highly simplified version of the complex supply 
chains of today. Mentzer et al. (2001) extend their definition of supply chain into a 
third, more complex, model: an ultimate supply chain. The ultimate supply chain is also 
shown in figure 1. 
The ultimate supply chain can be viewed as all the stakeholders that are involved in 
any exchange of information or material flows that occur between the ultimate supplier 
and the ultimate customer. The last supply chain in figure 1 exemplifies the complexi-
ties that may lie within a supply chain. In the ultimate supply chain financial provider, 
third party logistics firm and market research firm are introduced as new players in con-
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trast to the extended supply chain. The financial provider may be lending capital to both 
the immediate supplier and the organization essentially financing their operations. The 
third-party logistics supplier may be handling all the logistics from warehousing to 
transportation between two firms in the supply chain. The market research firm may be 
conducting a survey to the organization about its ultimate customers and their needs in 
regard to their products. All these entities form a complex supply chain that has many 
different aspects to consider and manage. (Mentzer et al. 2001; Harland, 1996) 
2.1.2 Supply chains in hospitals 
According to some studies, 30% to 50% of hospital costs are related to logistical ac-
tivities such as procurement, inventory management and provisioning (Poulin, 2003). 
Additionally, nearly half of these logistical expenses could be avoided with the use of 
best practices in logistical processes. Furthermore, it is generally accepted that infor-
mation and communications technologies are able to play a notable part in improving 
the health care supply chain (de Vries & Huijsman, 2011). Poulin (2003) suggests that 
activities in the hospital supply chain can be broken down into three sub-processes: or-
dering and managing supplies, receiving orders and replenishing user departments. Om-
baka (2009, 20) describes the procurement process as follows: “An effective procure-
ment process ensures the availability of drugs in the right quantities, available at the 
right time, for the right patient and at reasonable prices, and at recognizable standards 
of quality.” We will be examining the upstream processes, ordering and managing sup-
plies and receiving orders, more closely. The sub-processes are described in more detail 
in table 1.  
Table 1 Hospital logistics processes (adapted from Poulin 2003) 
Stock ordering and management 
Identify needs 
Create, process and track orders 
Review stores and pharmacy parameters 
Order receipt 
Take receipt of and check items 
Transfer and stock items in stores or the pharmacy 
Authorize payments to suppliers 
 
While examining the processes presented in Table 1, one must also consider the manual 
labor of health care professionals involved in all the activities while labor costs are the 
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single largest cost for hospitals. Nowadays, all these activities are driven by information 
systems. Information and knowledge exchange between suppliers and medical institu-
tions play key roles in supply chain management. Effective exchange of information 
and knowledge is not attainable without adequate investments in IT and other intangi-
bles such as trust between hospitals and its suppliers. While health care organizations 
are more than willing to invest in technologies directly involved in patient care, they 
oftentimes overlook the other end of the supply chain. Investments in supply chain 
management technologies can be beneficial to both the quality of patient care and the 
bottom line of the organization. (Chen et al. 2013)  
Figure 2 illustrates one possible logistics model for medical supplies and pharmaceu-
ticals. In some hospitals, there may be a separate purchasing unit, which coordinates the 
purchasing activities of hospital pharmacy, hospital stores and departments. However, 
all orders for pharmaceuticals go through the hospital pharmacy. In other hospitals, the 
stores and pharmacies may also order their products directly from manufacturers or dis-
tributors. The logistics model pictured in figure 2 has a two-echelon inventory system 
which is common for health care institutions (LaPierre and Ruiz, 2007). In two-echelon 
inventory system, both the care units (requesting department here) and stores hold in-
ventory and thus require inventory capacity. If a distribution center would be added in 
the figure, it would turn the inventory system into a three-echelon system. 
 
 
Figure 2 Hospital logistics (adapted from Poulin, 2003) 
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Acquisition activities happen in interface between health institution and distributors, 
as can be seen from figure 2. As noted earlier, the acquisition activities can be directly 
from pharmacies and stores or from a separate purchasing unit. Receiving and inventory 
activities happen in pharmacies and stores. In the pictured model of hospital logistics, 
stores handle the medical supplies and pharmacies deal with pharmaceuticals exclusive-
ly. Re-provisioning activities occur between hospital departments and pharmacies and 
stores. The stores and pharmacies receive orders from requesting departments and act 
accordingly. Storage and end use –activities are carried out in the requesting depart-
ments, which deliver the pharmaceuticals to patients and store some for later use. (Pou-
lin, 2003) 
Pan and Pokharel (2007) suggest that hospital logistics can be viewed as two main 
supply chains, internal and external. Due to the life and death nature of hospital logis-
tics, the service level requirements in the internal supply chain are imminent and should 
have negligible lead time. This creates two areas of focus for hospital supply chain 
management; internal- and external supply chain. Regarding the management of the 
internal supply chain, the key issue is maximizing the service levels while the manage-
ment of the external supply chain should concentrate on minimizing the costs. The lo-
gistics department plays an invaluable role in hospitals’ routine operations, as it can be 
accountable for purchasing, receiving, inventory management, transportation, food ser-
vices, medicine, home care services and inventory management system activities (Aptel 
and Pourjalali, 2001). Improvement in the logistics department can translate into cost 
reductions. 
LaPierre and Ruiz (2007) recognize two principal approaches how to manage func-
tions or actions within a health care supply chain: scheduling-oriented and inventory-
oriented. The inventory-oriented approach revolves around the basic concept of reorder 
point. Whenever a product in inventory reaches its reorder point in the requesting de-
partment, a replenishment signal is sent to stores or pharmacy. The needed products will 
be transported to the requesting department. Consequently, the inventory levels decrease 
in the pharmacy and the stores and eventually trigger a reorder point at which point the 
pharmacies and stores prepare purchase orders to external suppliers. LaPierre and Ruiz 
(2007) also note that a mere reorder point model alone is not efficient in the context of 
hospitals and faces three limitations. The limitations are: 
1. Model does not take limited human resources into consideration.  
2. Model does not account for limited physical inventory capacity, especially in 
stores and pharmacies which are imperative in hospital logistics. 
3. The decisions in the model are solely cost-based and do not account for in-
ventory activities. 
Replenishing inventories in the requesting departments tie up a lot of resources of the 
health care professionals. Hospitals have tackled the inefficiency problem by arranging 
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supply tours, which replenish many departments on the same runs. It is suggested that 
periodic replenishment model, where the replenishment decision is based on schedule 
rather than a reorder point, could suit health care organizations better. (LaPierre & Ruiz, 
2007) 
The limited storage capacities in the departments and pharmacies/stores are im-
portant while considering the reorder points. For example, stock-outs of certain pharma-
ceuticals may be life threatening and thus hospitals are not able to use the economic 
order quantity (EOQ) efficiently. EOQ is a calculated order quantity that minimizes the 
total holding and ordering costs. Also, stock-outs necessitate additional replenishment 
runs to the departments which effectively waste more time of the health care profes-
sionals.  (LaPierre & Ruiz, 2007) 
Thirdly, basing all replenishment activities in the reorder point model solely on costs 
does not consider the benefits of stock control. More frequent replenishment runs permit 
for quicker reactions to unusual demand, which enhances the service levels. Naturally, 
more frequent replenishment runs create more overall costs. (LaPierre & Ruiz, 2007) 
The alternative for inventory-oriented approach is the scheduling approach which 
can also be recognized as supply chain optimization approach. It concentrates on exam-
ining the supply chain as a chain of operational decisions; who purchases which prod-
ucts at what time and where are those products delivered? Also, the decision where to 
store what and how much are important for the supply chain optimization approach. 
(LaPierre & Ruiz, 2007) 
2.1.3 Supply chain integration and information systems 
As information technologies (IT) have been evolving throughout the recent years, the 
supply chain management has been deeply affected through integration. IT has enabled 
inter-organizational sharing of knowledge and real-time information within the supply 
chain in logistics, operations and strategic planning. This form of integration between 
supply chain partners has created better ways of predicting the future through enhanced 
inventory management, distribution and production planning. Without IT, the simulta-
neous decision-making enabled by transmission and processing of data would not be 
possible. Thus, IT can be seen as the key component in supply chain management and 
in supply chain integration. (Sanders 2007) 
Chen et al. (2013) determine three prominent factors, which affect supply chain inte-
gration the most: 
1. IT integration, 
2. Knowledge exchange and 
3. Trust between the supply chain partners. 
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Vickery et al. (2007) learned that car manufacturers’ IT integration with their first-
tier suppliers directly improved the performance of the whole supply chain. According 
to Sanders (2007) introduction of e-business technologies between supply chain part-
ners creates enhanced organizational performance both directly and indirectly via col-
laboration within an organization and inter-organizationally. Dyer and Chu (2003) noted 
that trust in the supplier-buyer relationship decreased transactional costs and increased 
information exchange in the automotive industry. Furthermore, according to their stud-
ies, trust and inter-organizational information sharing can be a source of competitive 
advantage. 
Chen et al. (2013) concluded in their study, which was based on survey data collect-
ed from 117 supply chain executives in U.S. that hospital-supplier integration enables 
supply chain-wide performance improvements in supply chain speed, quality, flexibility 
and costs. The hospital-supplier integration is facilitated by the level of knowledge ex-
change, IT integration and trust between the parties involved. Test results show that 
hospitals, which had greatly integrated their logistics systems with their supply chain 
partners, performed at a higher level throughout the whole supply chain. 
Study conducted by Gonzalez-Benito (2007) supports the notion that IT investments 
and IT integration within purchase function affect positively on performance in multi-
tude of operational areas. Moreover, the introduction of IT integration allows organiza-
tions to implement better purchasing practices, provided that it enables higher strategic 
integration of the purchasing operations. The more advanced purchasing practices, 
which efficiencies and synergies in information sharing facilitate, include supplier eval-
uation, collaboration with suppliers and logistics integration. These more sophisticated 
purchasing activities transform investments in IT into improvements in dependability, 
flexibility and quality on the operational level. Gonzalez-Benito (2007) concludes that 
“IT investment is key for the development and success of the purchasing function”. 
Figure 3 (de Vries and Huijsman, 2011) portrays the different stages of supply chain 
integration. All the phases should be interpreted as macro level development. It is also 
important to note, that many different organizations still are in one of the primitive stag-
es of supply chain integration, including health care sector. In the eyes of operations 
management, the health care sector has historically focused on optimization of individu-
al processes, such as optimal inventory levels of pharmaceuticals and optimal ordering 
processes for drugs, rather than the wide spectrum that is supply chain management. As 
we have seen with conventional manufacturing companies, most of the optimization 
problems in health care organizations have to do with how a high customer service level 
can be aligned with high resource utilization. It is still debatable among the academics 
how this kind of integration can be best achieved in health care supply chains. (de Vries 
& Huijsman, 2011) 
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Figure 3 Different stages of supply chain integration (adapted from de 
Vries & Huijsman, 2011) 
In figure 3, the phase 1 depicts the lowest level of supply chain integration. In phase 
1, the authorities and responsibilities are fragmented, optimization is local and the em-
phasis is on individual processes. Traditionally, health care sector can be seen to be in 
this phase. In phase 2, authorities and responsibilities are integrated within the organiza-
tion, central focus is on designing and controlling material flows on organizational lev-
el, emphasis is on coordination and interface questions and there is an organization-
wide information system. Phase 3 illustrates high level of supply chain integration. In it, 
there are established partnerships and alliances. The central focus is on designing and 
implementing inter-organizational information systems as well as integration of pro-
cesses (interface questions) between different organizations. In phase 3, the integration 
also reaches to market-development and collaboration between organizations on a sup-
ply chain level. 
Health supply chains can be defined by different levels of integration. De Vries and 
Huijsman (2011) identify six different levels of supply chain integration in health care: 
• Integration and co-ordination of processes. 
• Integration and co-ordination of information flows. 
• Integration and co-ordination of planning processes. 
• Integration of intra-and inter-organizational processes 
• Integration of market-approach. 
• Integration of market-development. 
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The deployments of e-business and information technology are tightly connected to 
the co-ordination and integration of operational activities. In addition, there are multi-
tude of different stakeholders related to health care supply chain. This makes it so that 
application of supply chain management methods in health care industry consist of, 
nearly by definition, allocating authorities and responsibilities, organizing interface pro-
cesses and building relationships. Supply chain integration in health care sector can be 
mainly seen as integration and co-ordination of planning processes, but it can also be 
viewed as joint market development and creation of new health care products. (de Vries 
& Huijsman, 2011) 
It is important to understand that the aforementioned levels of supply chain integra-
tion cannot be interpreted in a vacuum. Oftentimes an organization goes through multi-
ple different phases of integration simultaneously. In summary, the continuous shift in 
health care towards more integrated and process oriented supply chains necessitates an 
adjustment in structure, strategy and control mechanisms. (de Vries & Huijsman, 2011) 
In the following chapters we will be looking into different ways to improve the sup-
ply chain management performance. We will be looking into three different models how 
to set up the upstream supply chains and manage inventory; Just-In-Time (JIT), Vendor 
Managed Inventory (VMI) and Collaboration in Planning, Forecasting and Replenish-
ment (CPFR). First, we will examine the models overall and later, we will discuss their 
applications in hospital environments. 
2.2 Just-in-time JIT 
2.2.1 History of JIT 
Just-in-time, later on referred as just JIT, was seen in mid-2000s inherently as part of 
supply chain management, but in its early days in the 1970s and 1980s it was regarded 
as a tool to eliminate waste and reduce inventory (Giunipero et al. 2005). Throughout 
the decades it has been integral in lowering production costs, producing better quality 
products, achieving higher and faster throughputs, reducing inventory costs and having 
shorter lead times in purchasing. (Giunipero et al. 2005) The concept of JIT endorses 
the products to be delivered only in the right amount, to the right place at the right time 
(Hung et al. 2009). In this section we will be examining the JIT philosophy of inventory 
management and how it is applied in modern health care organizations as well as best 
practices which have emerged from JIT. 
Originally, JIT was created in Japan by Toyota Motor Corporation in the late 1970s. 
It started out as a Kanban system, where the production line uses Kanban cards to iden-
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tify when to order and request more supplies. Later on, it moved on to be called JIT 
after the US grocery industry adopted and renamed it. Basically JIT revolves around the 
basic concept of elimination of waste via continuous reorganization and improvement in 
manufacturing processes. (Giunipero et al. 2005) 
Academics also recognize two different modes of JIT; JIT manufacturing and JIT 
purchasing. JIT manufacturing refers to Japanese Kanban production methods where 
reduced manufacturing lot sizes, reduced manufacturing lead times and enhanced quali-
ty assurance programs are essential (Dong et al, 2001). Alternatively, JIT purchasing 
can be recognized as actions which enable reduction of raw materials in inventory, such 
as frequent deliveries with small lot sizes (Dong et al, 2001). Dong et al. (2001) suggest 
that while JIT purchasing benefits the buyer it might not necessarily benefit the suppli-
er. Moreover, Dong et al. (2001) identify four key elements of JIT purchasing: 
• Reduction in order size. 
• Reduction in order lead time. 
• Quality control measures (supplier quality certification, preventive mainte-
nance programs, receiving quality inspection). 
• Supplier selection and evaluation where suppliers are chosen based on geo-
graphical locations, product and delivery qualities in such manner that it fa-
cilitates aforementioned JIT purchasing practices. 
Two first elements can be seen as core elements in JIT purchasing and are essential. 
The latter two elements can be implemented separately or used with other supply chain 
practices such as vendor managed inventory. However, both of these must be imple-
mented in order for JIT purchasing to function. (Dong et al. 2001) 
2.2.2 Just-in-time logistics in hospitals 
It is important to note that it is difficult to implement just-in-time logistics in hospitals 
due to the nature of health care industry; patient safety is paramount and lack of medical 
supplies or pharmaceuticals can have detrimental consequences (Kumar et al. 2008; 
Trinkhaus et al. 1996). However, there is evidence supporting the use of JIT strategies 
in health care supply chains (Kumar et al. 2008). For JIT to be viable way of managing 
inventory, it needs to fulfill the following criterion: the supply chain activities need to 
be high volume, repetitive and deal with concrete items (Jarrett, 1998). The mentioned 
criterion must be combined with good relationships with suppliers in order to enable JIT 
deliveries (Kumar et al. 2008). Trinkhaus et al. (1996, 2) strengthen this evaluation by 
stating that “Having reliable vendors deliver smaller quantities at more frequents inter-
vals allows the firm to reduce the size of its inventory while still ensuring the integrity of 
its production schedule.”  
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Kumar et al. (2008) conclude that if health care organizations wish to implement lean 
JIT strategies, they need to make two operational changes. Firstly, they need to seek 
collaboration with their suppliers through partnerships and co-operation. Secondly, they 
need to identify whether or not their current supply chain systems are capable to accu-
rately support logistic decision making. It is also necessary to acknowledge that phar-
maceuticals are highly regulated part of health care industry (Kumar et al. 2008). For 
instance, in Finland, there is also a minimum stock requirement for certain drugs 
(finlex.fi) which makes deployment of JIT strategies more difficult. In a survey study of 
75 U.S. hospitals conducted by Kumar et al. (2008), they found out that many of the 
hospitals in the U.S. already had the infrastructure and capabilities to move into leaner 
JIT environment. 
Traditionally, the majority of JIT systems in hospitals have been founded on the ba-
sis of outsourcing the logistics operations to a third-party logistics provider. The noted 
benefits of this consist of stock reduction, less time spent by health care specialists on 
the inventory management activities and less administrative activities for health care 
workers. However, there are also negatives sides to the use of third-party logistics pro-
viders; hospital may lose control over selection of products and if the relationship with 
its service provider lacks trust, it may cause the whole system to hinder. Also, if the 
implementation of the JIT system fails, it is hard to return to the old system. Pan and 
Pokharel (2007) noted in their study of Singaporean hospital logistics that outsourcing 
did not always reduce the costs of services and products in hospitals. To conclude, the 
success of an implementation of JIT system ultimately is tied to the ability to choose 
capable and trustworthy providers. (Trinkhaus et al. 1996)  
Jarrett (2006) states that implementation of JIT systems and reengineering of hospital 
supply chains will be imperative for the health care industry to obtain control over the 
ever-rising costs. Prior to assessing the return on investment and estimations of the suc-
cess factors of JIT systems, the health care management has to figure out answers to 
multiple questions. Firstly, what has been the stopping force that has kept the health 
care industry unwilling to adopt the equivalent competitive operational processes used 
in distribution and manufacturing industries? Secondly, there are many similarities in 
business processes between the aforementioned industries, particularly in the domain of 
inventory control, product production and supply distribution. Third, management needs 
to create an understanding on why these changes have not been seen as crucial before. 
(Jarrett, 2006) 
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2.3 Vendor managed inventory VMI 
2.3.1 Different modes of VMI 
Despite the JIT systems historically being prominent in the health care industry’s inven-
tory management, there has been continuously more interest and emphasis on different 
inventory control systems such as Vendor Managed Inventory (VMI) (Mustaffa & Pot-
ter, 2009). In VMI, the supplier will be responsible, partly or wholly, for the manage-
ment of inventory and makes the decisions with respect to replenishment. According to 
Mustaffa and Potter (2009), VMI has similar requirements regarding information as a 
stockless inventory system, the biggest difference being the fact that the supplier will be 
accountable for controlling the stock and inventory levels since the ordering process is 
automated. In order for VMI to work to good effect, there must be timely and accurate 
information regarding consumption and current stock levels. To enable this, there needs 
to be some level of systems integration between the supplier and customer and invest-
ments made into the current ICT systems. (Mustaffa & Potter, 2009) 
VMI offers a mutually beneficial setting for both supplier and buyer. In a true form 
of VMI, the supplier is free to make decisions and plans how and when to produce and 
replenish with respect to the customer-agreed service levels. The buyer receives benefits 
from administrative and inventory cost reductions simultaneously shortening lead times 
and limiting the risk of amplification of demand within the supply chain. In turn, the 
supplier is able to optimize transportation costs and create a steady and lean production 
plan. Prerequisites for these benefits are sharing of information throughout the supply 
chain and mutual trust. Mutual trust can be broken down into honesty, frequency of in-
teraction, chemistry between parties, commitment, interdependency, openness and trust. 
Information sharing can be further dissected into completeness, information availability, 
reliability and information sharing (Claassen et al., 2008). 
Kauremaa et al. (2009) identified three different patterns of VMI implementation:  
• Basic VMI 
• Cooperative VMI 
• Synchronized VMI. 
The three patterns of VMI implementation, their motivations and outcomes are pic-
tured in figure 4.  
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Figure 4 Patterns of vendor managed invetory (adapted from Kauremaa 
et al. 2009) 
In basic VMI implementation, VMI is used at its basic level of shifting the responsi-
bility of replenishment to the supplier in tandem with increasing need of information to 
carry out the responsibility. Basic VMI is characterized by one-sided but supplementary 
ambitions. The buyer’s objectives in basic VMI are ease of supply and superior opera-
tional efficiency. On the other hand, the supplier pursues to maintain or improve its 
commercial position in the market. This is achieved via the inter-organizational system, 
which can be seen as a structural relationship-marketing program. This translates into 
value-based differentiation. The buyer’s goals are met in basic VMI if the purchasing 
operations are made lighter, more effective and more efficient as the ordering process is 
removed from the equation. Material availability will increase and inventory levels will 
decrease. The supplier’s goal is achieved if the VMI service is implemented successful-
ly. (Kauremaa et al. 2009) 
In cooperative VMI the interests of the two parties are mutual and the aim is to im-
prove the whole supply chain. Both the buyer and supplier aspire to operational effi-
ciency. Moreover, what is unique for the cooperative VMI is the alignment of end-goals 
and collective actions. Whereas in basic VMI the supplier’s focus was in product avail-
ability, in cooperative VMI the target has shifted more towards the end-customer and its 
needs. The cooperative VMI process enables more transparent and visible needs and 
material resources for the two parties working together to achieve minimum inventory 
and maximum availability. As a by-product, cooperative VMI creates an inter-
organizational atmosphere where collective development ventures and open and sup-
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portive dialogue regarding non-VMI subjects can be had. To conclude, in comparison to 
basic VMI, cooperative VMI can be viewed as more intricate way of improving con-
necting more interdependent organizations within a vertical supply chain. (Kauremaa et 
al. 2009) 
The third mode of VMI implementation is synchronized VMI. Synchronized VMI 
can be viewed as an improvement over the former two VMI patterns, basic and coopera-
tive VMIs. In synchronized VMI, the supplier thrives to integrate the inter-
organizational program with the use of downstream information in its decision making 
as well as in seek of operational effectiveness. For synchronized VMI to succeed, it re-
quires the distinct intent from supplier’s part to have the VMI in the center of its inter-
nal operations and planning. Although synchronized VMI is one possible implementa-
tion model, Kauremaa et al. (2009) noted that it is hard for the suppliers to harness all 
the benefits of the inter-organizational visibility created by VMI and thus harder to im-
plement. (Kauremaa et al. 2009) 
2.3.2 Benefits and risks of VMI 
VMI aims to reduce lower inventory level and, at the same time, improve service levels. 
For this to be possible there needs to be good visibility and communication between 
supply chain members. Kim (2005) found out that health care organizations which had 
adopted VMI could see up to 30 % stock reductions in pharmaceuticals, as well as other 
benefits. With VMI, the flow of information and materials becomes more harmonious, 
service levels improve, transportation and inventory costs decrease and the supply chain 
as a whole is more coordinated. Traditionally, the lowering of inventory levels and sim-
ultaneous improvement of service level has been seen contradictory but through VMI 
this can be achieved. Table 2 gives an overview of the various risks and benefits which 
retailers and vendors face by entering in a VMI program. (Guimaraes et al. 2013).   
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Table 2 Benefits and risks of VMI (adapted from Guimaraes et al. 2013) 
Retailer Vendor 
VMI Benefits VMI Risks VMI Benefits VMI Risks Reduce inventory and cost Information visibility al-lows opportunistic behav-ior 
Increase inventory flexibility Order process is not abandoned by cus-tomer 
Fewer stock outs Dependency on vendor Reduce lead time variability Initial technology investment 
Increase service lev-els/product availability Switching costs Consistent ordering pattern Difficulties in techno-logy integration 
Fill rates improvement  Reduce transportati-on costs 
 
Increse inventory turns  Optimize physical distribution 
 
Reduce transactional costs  Warehouse efficien-cy 
 
Reduce ordering and plan-ning costs 
 Real time access to information 
 
  Competitive advan-tage relationship 
 
According to Guimaraes et al. (2013), there are two main drivers for VMI: information 
sharing and decision making. Out of these two, information sharing is the force that 
creates all the performance benefits (fill rate improvements, reduction of transactional 
costs, reduction of stock outs etc.). The vendor can enjoy these perks only if it begins to 
use collaborative information sharing technologies and programs. It has also been 
acknowledged, that more simple information systems in VMI yield better results regard-
ing effectiveness than complex information systems. Claassen et al. (2008) concluded in 
their study that the quality of information systems is a strong enabler for VMI imple-
mentation success and it provides the following: 
• information availability and visibility 
• decisions based on total information within the supply chain 
• collaboration between parties in the supply chain 
• single point of contact for data. 
It is important to note that disregarding the risks associated with VMI prevents both 
parties from benefiting from the arrangement; this is where one needs to consider the 
decision-making component. 
Dong and Xu (2002) claim that retailer is the main beneficiary in VMI arrangements 
only if the relationship is short term. Conversely, long term arrangements benefit the 
vendor more as they will be able to better predict future demand. Overall, even though 
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both parties benefit from VMI systems, vendor can be interpreted to enjoy more bene-
fits from the arrangement. 
2.3.3 VMI systems in hospitals 
Traditionally, the problem with inventory management in hospitals has been the fact 
that the actual inventory levels reflect the desired inventory levels of the medical staff 
rather than the needed inventory levels. Furthermore, the decisions regarding inventory 
are oftentimes politically driven and experienced based instead of data-driven decisions. 
This might cause overstocking and create waste in the supply chain.  (Nicholson et al., 
2004) 
Despite the willingness to improve supply chain management within health care or-
ganizations, the health care industry as a whole has its unique ways of implementing the 
best practices in SCM. Some limitations regarding implementation of best practices are 
misaligned or conflicted interests, limited education, inconsistencies in relationships 
between purchasing organizations and supply chain partners and lack of executive sup-
port. Even if the best practices are implemented, there still remains hindering aspects 
regarding efficiency in the supply chain. Such hindering aspects can be health care pro-
fessionals’ preferences, limited information sharing, evolving technologies, lack of 
standardized codes and lack of SCM knowledge and skills. Overall, the unwillingness to 
implement VMI systems in health care environment stems from the lack of information 
about the benefits and shortage of sufficient training. (Guimaraes et al., 2013) 
Pan and Pokharel (2007) discovered in their study that VMI can be utilized in hospi-
tals to decrease stock levels and reduce logistics costs. For VMI to be effective, hospi-
tals need to have functioning information systems which support electronic commerce 
and the suppliers need to be from local area in order to secure the uninterrupted flow of 
materials (Pan & Pokharel, 2007). In VMI programs, with the assistance of integrated 
VMI software, it will become easier to predict future demand of medical supplies and 
pharmaceuticals in hospital settings. Orders are created based on automated economic 
ordering quantity calculations taking into consideration lead time, safety stock, excep-
tional demand and seasonality. Electronic data interchange (EDI) controls the infor-
mation flows and lowers the costs of communication and collection of data. By transfer-
ring the purchase order creation activity to distributors, hospitals are able to reduce er-
rors in procurement process as well as manual labor by the health care professionals 
which ties up resources from their actual work. (Guimaraes et al., 2013) 
Guimaraes et al (2013) determined it to be easier to implement VMI programs to 
pharmaceuticals. This is to some extent due to the ability and knowledge of the pharma-
ceutical companies over SCM best practices and information systems involved. It can 
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be even stated that pharmaceutical companies have positioned themselves strategically 
to be able to provide VMI and other IT solutions regarding SCM. 
In their study, Guimaraes et al (2013) found out VMI to be a lean solution for hospi-
tal material management. Despite the aforementioned implementation barriers of the 
health care sector, VMI provides multiple benefits such as increased replenishment effi-
ciency, reduction of waste, streamlining of the material and information flows via visi-
bility throughout the supply chain, lowered inventory costs and improved quality of care 
due to the freed resources from the purchasing activities. It is imperative to understand 
that, as in any lean solution, VMI requires continuous improvement and attention in 
order to provide desired results. 
2.4 Collaboration in planning, forecasting and replenishment CPFR 
2.4.1 CPFR model and contingent factors 
Collaborative planning, forecasting and replenishment, later on referred to just CPFR, 
can be defined as “… collaboration where two or more parties in the supply chain joint-
ly plan a number of promotional activities and work out synchronized forecasts, on the 
basis of which the production and replenishment processes are determined” (Larsen et 
al, 2003, p.532).  
As is evident from the definition, CPFR has three sub-processes; planning, forecast-
ing and replenishment. These three can be further divided into nine steps. These steps 
are presented in figure 5. The main focus of CPFR is to pursue to complete and evolve 
the previous supply chain management methods, such as vendor managed inventory, 
just-in-time logistics or continuous replenishment. CPFR can be seen as a broader varia-
tion when compared to other collaborative models. (Danese, 2007) 
According to Larsen et al (2003), CPFR can take many forms depending on the level 
of implementation. The authors classify CPFR in three tiers; basic, developed and ad-
vanced. The level of implementation is dependent on two factors: scope of the collabo-
ration; how many business processes are involved and depth of the collaboration; indi-
cating the integration of business processes. Danese (2007) extends that CPFR is modu-
lar model in a sense that it is not mandatory to implement all nine steps of the model in 
order to gain benefits. 
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Figure 5 CPFR activities (adapted from Danese, 2007) 
The first step in CPFR is for the parties involved to agree to commit to a program of 
collaboration in demand forecasting. This includes also determining the key metrics and 
sponsors within all organizations. The second step is to create a joint plan addressing 
item management profiles, which include lead times, promotions, minimum order quan-
tities and reorder frequencies. Next, the collaborating parties create a sales forecast 
aligned with the joint business plan based on actual consumption data collected from all 
parties. Steps four and five concentrate on identifying and resolving issues and excep-
tions with the sales forecast. These can be, for example, inaccuracies in forecasts, exe-
cution problems or over/under stocking. All these variables force the parties to readjust 
their initial joint sales forecast. In conjunction with steps one to five, the parties are now 
able to combine the information and planning into a more accurate order forecast. This 
enables the seller/distributor to prepare production schedules according to demand while 
simultaneously minimizing safety stock. Steps seven and eight are similar to steps four 
and five where deviations and exceptions to order forecast are identified and resolved. 
Finally, by accruing all the collaborative planning and information gathered throughout 
the process, a replenishment plan can be established by turning the order forecast into a 
binding order. (Danese, 2007) 
According to Danese (2007), the different types of CPFR arrangements are contin-
gent on five factors: CPFR goals, CPFR development stage, supply network’s relation-
al/physical structure and characteristics of products and their markets. Investigating 
these five factors will allow better understanding of the depth of collaboration between 
parties and also clarifies the number of interacting units and processes in the collabora-
tion setting.  
Danese (2007) determined in her research that companies engage in CPFR for two 
main reasons: reducing costs and transforming the supply network more agile. In the 
former, the aim is to reduce costs, e.g. investments in inventory, while maintaining the 
same service level. This could be characterized as “strategy of efficiency”. The latter 
focuses in adapting the supply chain to fluctuations in demand, making it more respon-
sive. Hence, this can be characterized as “strategy of responsiveness”. Danese (2007) 
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also discovered that for companies aiming to achieve efficiency through CPFR, the lev-
el of collaboration required was low. Communication of data was enough for the ar-
rangement to reap benefits. Communications can be seen as exchange of data on sales 
plans, stock data or order forecasts. On the other hand, if companies sought to be more 
responsive to changes in demand, it required much deeper collaboration between in-
volved parties. Alongside exchange of data, companies need to jointly manage their 
expectations and synchronize their plans. 
The depth of collaboration is contingent on supply chain network’s physical structure 
and product/market characteristics. Product and market characteristics in question are 
elasticity of demand, spatial complexity (geographical distance between collaborators) 
and homogeneity of products. If product has high elasticity of demand, significant 
changes in shelf prices, e.g. promotions, may affect the demand greatly. In the case of 
high elasticity of demand, collaborating parties need to have high level of collaboration 
in order to response to fluctuations in demand and create more accurate demand fore-
casts and plans. For high level of collaboration, it is also required that supply chain net-
work’s physical structure has low spatial complexity. If the geographical distance be-
tween collaborating parties is high, it limits the collaborations. Furthermore, the homo-
geneity of products determines the level of collaboration in relations with demand elas-
ticity and spatial complexity. While collaborating parties market and sell similar prod-
ucts, it is easier for them to collaborate on a deeper level. If all part ies are familiar with 
the marketplace, they are able to better assess demand fluctuations and better collabo-
rate in creating demand forecasts and plans. Different products always limit the depth of 
collaboration but even though parties have similar products, this does not necessarily 
create a good environment for high level collaboration if the spatial complexity is high 
and/or demand elasticity is low. (Danese, 2007) 
The nature of relationships within a supply chain network’s relational structure has 
great effect on the number of interacting units. As in many other SCM practices, also in 
CPFR trust and good relationships are important factors when choosing a supplier or a 
partner to cooperate with. Also, existing supply chain integrations affect the decision to 
do cooperation with other organization; if some parts of the supply chain are already 
integrated, it lowers the threshold to commit in collaboration. Reflecting on the nature 
of relationships, collaborating parties may evaluate the number of potential partners. 
Danese (2007) discovered in her study that if the number of potential partners is low, 
then also the number of interacting units is low. In turn, if the number of potential part-
ners is high, this may enable more interacting units. Another determining factor for the 
number of interacting units is the development stage of CPFR. If CPFR is still in initial 
stage, it typically limits the number of interacting units. On the other hand, if CPFR is in 
advanced stage, this permits for more interacting units. To summarize, for high number 
of interacting units in a CPFR setting, it is required that the amount of potential CPFR 
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partners is high and an advanced stage of CPFR has been established. Furthermore, if 
CPFR is still in its initial stages or the number of potential CPFR partners is low, the 
number of interacting units is low. Figure 6 demonstrates the different modes and paths 
a CPFR can take.  
 
 
Figure 6 Relationships between contingent factors & CPFR collabora-
tions (adapted from Danese, 2007) 
2.4.2 CPFR in hospitals 
Lin and Ho (2014) performed 13 interviews with medical experts in 11 Taiwanese hos-
pitals in order to better understand the implications and possibilities of CPFR imple-
mentation in health care environment. The interviewees had varying range of experience 
between 5 to 30 years and were mainly responsible for procurement of pharmaceuticals. 
The study showed that 90 % of the Taiwanese hospitals did not utilize integrated infor-
mation systems with suppliers and approximately 80 % of the hospitals were concerned 
with asymmetric information flows with their pharmaceutical suppliers. The lack of 
communication and information sharing between the two parties resulted in frequent 
overstocking and stock-outs. Furthermore, 9 out of 11 hospitals also were not content 
with their existing e-procurement systems. In conclusion, Lin and Ho (2014) determined 
that the current pharmaceutical procurement processes in most of the hospitals were 
highly manual labour extensive and were characterized by waste of employee resources.  
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According to Lin and Ho (2014) CPFR could be a viable solution for hospitals in bat-
tling with issues in pharmaceutical procurement process. In their study, they categorized 
the benefits of CPFR implementation in hospitals in three classes: quality, cost and 
time. The benefits are presented in table 3. It is important to note that the different type 
of benefits apply to different kind of hospitals in varying degrees. As a rule of thumb; 
the larger the hospital, the larger the benefits. 
Table 3 CPFR benefit analysis (adapted from Lin and Ho, 2014) 
Class Benefit (%) 
Cost     
Time  
Quality 
1. Reduce stock cost (20-40) 2. Save stock space (3-10) 3. Save labor cost (30) 4. Reduce shipping fee (5-15) 5. Save paper usage (90-99) 
1. Save purchase time (40) 2. Reduce delivery time (1-2 days) 
1. Promote service quality (1-5) 2.   Rise forecast accuracy (10-20) 3. Reduce shortage rate (2-10) 4. Reduce urgent order rate (5-20) 
 
As in any endeavor to enhance the supply chain, the main goal is to reduce costs and 
improve operational effectiveness. Table 3 shows that CPFR can reduce stock costs up 
to 40 % and save labor costs up to 30 %. Also, lead time can be reduced and effectively 
enhance service quality and limit shortages. This is increasingly important in a health 
care context where the costs of shortages can amount to lost human lives.  
Bhakoo et al (2012) refined the five contingent factors of CPFR arrangements by 
Danese (2007) to better fit in a health care setting and illustrated that they can also be 
applied. The five contingent factors are:  
1. Spatial complexity 
2. Regulatory environment 
3. Product characteristics 
4. Physical characteristics 
5. Degree of goal congruence. 
Spatial complexity can be high or low and Bhakoo et al. (2012) suggest that if a sup-
ply chain partner has high spatial complexity, the inventory should be managed via in-
ternal control methods. In the case of low spatial complexity, it is possible to manage 
inventory with methods that take advantage of collaborative arrangements with supply 
chain partners.  
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Regulatory environment can be high or low. Bhakoo et al. (2012) propose that if the 
regulatory environment is low, it is feasible to manage inventory via methods that use 
collaborative arrangements with trading partners. On the other hand, if the regulatory 
environment is high, the inventory should be managed with methods using internal con-
trols.  
Product characteristics are divided into functional or innovative; internal controls 
work better for innovative products as an inventory management method. Functional 
products can be managed with methods that incorporate collaborative arrangements 
with suppliers. (Bhakoo et al. 2012) 
Physical characteristics are either limited or abundant. Abundant physical character-
istics refer to larger hospitals with well utilized, advanced IT infrastructures and ade-
quate storage possibilities. At the same time, limited physical characteristics denotes to 
smaller hospitals with elemental utilization of IT infrastructure and limited storage ca-
pabilities. According to Bhakoo et al. (2012), internal control methods are better suited 
for limited physical characteristics. On the other hand, organizations with abundant 
physical characteristics are able to utilize collaborative arrangements with suppliers.  
The degree of goal congruence can be high or low. In the case of aligned goals where 
the congruence is high, the suited method of inventory management incorporates col-
laborative arrangements with suppliers. If the goals of the supply chain partners are not 
aligned and the congruence is low, it is beneficial to manage inventory via methods of 
internal controls. Figure 7 summarises these aforementioned contingent factors. 
(Bhakoo et al. 2012) 
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Figure 7 Contingent factors affecting the development of collaborative 
relationships across the health care/hospital supply chains 
(adapted from Bhakoo et al. 2012) 
Figure 7 shows that the ideal conditions for collaboration for health care organiza-
tions are in a low spatial complexity setting where the products are functional (high de-
mand and high supply elasticity) and there is low level of regulations. The larger and 
more developed health care organizations benefit more and are more capable of collabo-
ration. With high degree of goal congruence, the parties in a supply chain are more in-
clined to collaborate than when the parties had conflicting aspirations.  
In their study, Bhakoo et al (2012) also recognized multiple challenges the hospitals 
and pharmacy departments faced while seeking collaboration with suppliers. Trust is-
sues between suppliers and hospitals was the most prominent obstacle in creating col-
laborative arrangements. While large multinational pharmaceutical companies’ main 
goal is to maximize profits to its shareholders, the public hospitals are non-profit and 
this leads to lack of confidence between supply chain partners and lesser degree of in-
formation sharing.  
The second challenge Bhakoo et al (2012) noticed was aforementioned divergent 
goals between the pharmacy departments in the hospitals and the pharmaceutical com-
panies. The hospitals recognize that collaborative arrangements with profit maximizing 
entity open up growing dependencies, which might lead to opportunistic behaviour. 
Other cause of goal incongruity, according to the study, stems from the pharmacy de-
partments objective to secure patient safety and uneasiness to hand over the control of 
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pharmaceutical inventory management to a third-party supplier. Related to inventory 
management, pharmacy departments emphasize the importance of ensuring that re-
quired stock levels are maintained at the supplier prior to establising a VMI process as 
stock-outs can have mortal consequences. 
Physical and technical infrastructure was also mentioned as an obstacle for collabo-
rative VMI arrangements. Based on the interviews with hospital pharmacists, the con-
cern was that the hospitals would not have adequate physical infrastructure to support 
necessary storing of items. This was particularly apparent in larger and heavier products 
such as intravenous fluids. The literature emphazises the significance of information 
sharing and information systems in collaborative arrangements, i.e. VMI. Large portion 
of pharmacists in hospitals were not convinced that satisfactory systems could be im-
plemented without major problems and economically. (Bhakoo et al. 2012) 
For collaboration between hospitals and suppliers to be successful and financially 
feasible, Bhakoo et al (2012) determined the size of the hospital to be a critical factor. 
Larger bed count correlates with greater requirement for medicines and consequently 
larger storage facilities. This in turn enables greater cost reductions if collaborative VMI 
arrangements are utilized. 
The last barrier, according to Bhakoo et al (2012), for entering in collaborative ar-
rangements with pharmaceutical suppliers is cultural inertia. The fear of losing control 
over important clinical functions, i.e. investigating the latest drugs on the market or 
looking for more inexpensive alternatives, lead the directors of hospital pharmacies to 
be sceptical of collaboration with suppliers. Furthermore, the pharmacists envisioned 
that they would not be able to follow the trends of medicine consumption and the rea-
sons behind the fluctuations. Ultimately, Bhakoo et al (2012) construed this as a fear of 
becoming useless on the part of the hospital pharmacists. 
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3 RESEARCH FRAMEWORK 
The research framework for this study will expand on the literature reviewed and at-
tempt to fit the previously discussed themes into the context of Finnish health care, 
more specifically the procurement of pharmaceuticals in Finland. The Finnish health 
care system has been hailed as one of the best in the world and its regulation on phar-
maceuticals has multiple unique characteristics (Sitra, 2009). This necessitates creation 
of a completely new framework in studying the possibility of collaborative arrange-
ments within the pharmaceutical supply chain of hospital pharmacies in Finland.  
3.1 Unique characteristics of pharmaceutical industry in Finland 
3.1.1 Mandatory reserve supplies 
In the context of this study, we will be discussing only about the regulations and charac-
teristics connected with the hospital pharmacies. The unique characteristics of Finnish 
pharmaceutical regulations are mandatory reserve supplies and single channel system. 
We will be examining these two characteristics in more detail.  
Finland is geographically disadvantageously located in regard to medicine supply. It 
is mainly surrounded by water in logistically relatively challenging location in the 
northern parts of the world. Alongside the logistic challenges, substantial seasonal 
changes in temperatures create difficulties for medical transportation. Furthermore, Fin-
land only has one pharmaceutical factory compared to 15 factories from 20 years ago 
and infusion liquids are not manufactured in Finland, at all. Adding to the already pecu-
liar circumstances, is the fact that Finland does not possess any original molecules used 
in pharmaceutical manufacturing; all the molecules are imported from other countries. 
(Interview with head pharmacist, 20.4.2016; STM 2018) 
To ensure the availability of medicines in a catastrophic event, the Finnish govern-
ment introduced The Act on Mandatory Reserve Supplies (979/2008) which aims to 
“ensure the availability of medicines in circumstances in which such availability is re-
stricted or prevented as a result of suspension of deliveries, a serious crisis or other 
equivalent reason.” The act was first introduced in 1984 and has been since revisited 
multiple times. Basically, pharmaceutical companies, importers, health care units and 
the National Institute of Health and Welfare are required to stock certain medicines 
based on the average consumption of said medicines. The requirements vary between 
parties; health care units are required to stock quantities, which correspond with the 
average consumption during the first 9 months of the previous year. Pharmaceuticals are 
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divided into three medicine groups and each group is assigned a mandatory stock re-
quirement based on the average consumption of either 2 weeks, 3 months or 6 months. 
All the parties, to which the Decree concerns, are required to report to the Finnish Med-
icines Agency, FIMEA. (fimea.fi) 
FIMEA will revisit and confirm the list of items to be stocked as mandatory reserve 
supplies yearly. The list includes “products which have a critical medical significance 
and which have active pharmaceutical ingredients listed in the Decree of Mandatory 
Reserve Supplies of Medicines (1114/2008). Supplies also include excipients and addi-
tives and packaging materials used in the manufacturing of medicinal, if the party sub-
ject to maintaining the mandatory reserve supplies, storages active pharmaceutical in-
gredients instead of medicinal products.” (fimea.fi) 
In formulating the research framework, the mandatory reserve supplies must be taken 
into consideration. For pharmaceuticals with short expiration periods, it is not plausible 
to eliminate waste entirely due to the mandatory reserve supplies. The mandatory re-
serve supplies also create pressure for the supplier and ties up storage space in a collab-
orative VMI arrangement.  
3.1.2 Single-channel system 
Single channel system is the other unique characteristic of Finnish pharmaceutical mar-
ket. Single channel system refers to a system where a wholesaler has exclusive rights to 
distribute medicines of a certain manufacturer. In the EU area, the only other country to 
have a single channel system is Sweden. Typically, in single channel countries, the 
number of wholesalers is limited. In Finland, there are three main wholesalers of which 
two are significantly larger. There are also some smaller suppliers but the amount of 
medicines ordered is negligible.  
The single channel system has its weaknesses and strengths; it effectively prevents 
counterfeit pharmaceuticals entering the legal supply chain. Alongside with other regu-
lation, it has been shown that in the single channel system, the wholesale prices, and in 
conjunction the retail prices, are among the lowest in Europe (Kanavos et al. 2011). On 
the other hand, the single channel system is susceptible to disruptions in the distribution 
chain. This was extremely evident in autumn 2017 when the other large wholesaler, 
Oriola with some 40 % market share, rolled out its new ERP system unsuccessfully. 
The failed implementation caused a five-week disruption in the pharmaceutical deliver-
ies and cost the company estimated 5 million euros (tivi.fi, 2017). While in a multi-
channel system, the hospital pharmacies could have adapted to the supply chain disrup-
tions by ordering the same product from a different supplier, in the single channel sys-
tem, the hospital pharmacy was reliant on deliveries from the single provider.  
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Hospital pharmacies in Finland are public entities and thus they are tied to the cur-
rent legislation on public procurement and tenders. The prices are fixed throughout the 
two- to three-year agreement period. (STM, 2018) 
The single channel system affects directly collaborative supply chain arrangements 
and thus, it is important to take it into account in the research framework. Next, we will 
be discussing the research framework. 
3.2 The framework 
Adapting from Danese (2007) and Bhakoo et al (2012), the research framework will be 
combining the contingent factors with the unique charachteristics of Finnish pharma-
ceutical industry, which affect the viability of CPFR and VMI arrangements. The pur-
pose of the framework is to guide the empirical research and attempt to establish the 
pain spots where medical waste might occur in the upstream pharmaceutical logistics 
process within hospitals.  
 
 
Figure 8 The research framework 
The framework suggests that CPFR and VMI arrangements would be a good instru-
ment in reducing waste and costs within the upstream logistics process for pharmaceuti-
cals in Finnish health care setting. It describes how the unique characteristics of Finnish 
pharmaceutical industry could make it a good fit for CPFR and VMI arrangements. Fig-
ure 8 demonstrates the contingent factors affecting the success of CPFR and VMI ar-
rangements. 
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The research framework consists of six different contingent factors; supply chain 
networks’ relational structure, regulatory environment, spatial complexity, goal congru-
ence, product characteristics and physical characteristics. The information system can 
be seen as key enabler that ties everything together. 
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4 EMPIRICAL RESEARCH 
First, this chapter will outline the research methodology used for this study, describe the 
data collection and analysis methods and discuss the reliability of the research. After-
wards the results of the study will be presented.  
4.1 Research methods 
4.1.1 Case study methodology 
In this study, a case study methodology will be employed. Case study is the preferred 
research strategy when the questions are presented as to “why” and “how”, when the 
events are not in the control of the researcher and when the focal point is on a contem-
porary occurrence within some real-life context (Yin 2003, 1). The subject of this study 
is a process to which there is little to no control over the events. Additionally, the sub-
ject is a contemporary phenomenon with real-life context. Gerring (2004) extends this 
and describes a case study as “an intensive study of a single unit for the purpose of un-
derstanding a larger class of (similar) units”. In the context of this study, the Universi-
ty hospital of Turku and its hospital pharmacy represent accurately the setup for all five 
University hospitals located in Finland. In addition, all the related external factors such 
as regulations and suppliers apply explicitly to all the units. Therefore, a case study 
methodology can be seen as a suitable method for the research purposes. 
“A research design is the logic that links the data to be collected (and the conclu-
sions to be drawn) to the initial questions of study” (Yin 2003, 19). That is to say, it 
defines the way of performing a research and outlines the frame of the research. A 
qualitative study is chosen for this research as it supports the research purposes. The use 
of case study methodology enables a comprehensive analysis of the subject through 
interviews with interviewees possessing different knowledge and perspective of the 
study subject.  
Yin (2003, 39) identifies four different types of designs for case studies; single-case 
(holistic), single-case (embedded), multi-case (holistic) and multi-case (embedded). 
These four differing types of case studies create a two by two matrix (figure 9). The 
common denominator for every type of design is the aspiration to analyze the case rela-
tive to the contextual factors. As can be interpreted from the matrix, the lines between 
the case and the context are not solid and reflect the ambiguous nature of the two.  
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Figure 9 Case study design types (adapted from Yin, 2003) 
It can be further recognized from the matrix that single- and multiple-case studies 
portray two distinct design circumstances and that within these two variations, there 
may be a single unit (holistic) or many units (embedded) of analysis (Yin 2003, 39). 
Before entering the data collection phase of a research, there needs to be a decision 
made regarding the primary distinction in designing case studies; single-case study or 
multiple-case study.  
4.1.2 Single-case design 
For a single-case design to be appropriate study method, Yin (2003, 39-42) presents five 
rationales. Additionally, to reinforce the point, Yin compares a single case study to a 
single experiment as many of the same conditions apply equally. The five rationales are: 
• Critical case 
• Extreme or unique case 
• Representative or typical case 
• Revelatory case 
• Longitudinal case. 
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Critical case denotes a single case, which is the most relevant case in testing a clear-
ly formulated and specified theory. The theory has distinct set of presuppositions, and in 
conjunction, a set of conditions within which those presuppositions are assumed to be 
factual. If a single case meets all the required circumstances, it may be able to chal-
lenge, extend or confirm the theory in question. With all the required circumstances 
met, the single case may be used to conclude whether the presuppositions are indeed 
appropriate or whether some other factors might be more suitable. (Yin 2003, 40) 
Regards to extreme or unique case, Yin (2003, 40-41) gives an illustrative example 
from a common occurrence in clinical psychology. Certain dysfunctions might be so 
uncommon and exceptional that even a singular case can be worth researching and doc-
umenting. In this case, a single-case study design is appropriate. 
Inversely, for a representative or typical case, a single-case study can be a valid re-
search design.  In representative or typical case, the case portrays the conditions and 
circumstances of a typical or general occurrence. For example, a hospital might be rep-
resentative of an archetypical hospital among similar hospitals or a marketing agency 
might represent a typical marketing agency in the industry. The findings from repre-
sentative or typical cases can be presumed to be illustrative about the experiences of the 
ordinary organization or individual. (Yin 2003, 41). 
With revelatory case Yin (2003, 42) refers to a single case, where there is a possibil-
ity to research and investigate formerly inaccessible phenomenon. Yin cites Liebow’s 
(1967) renowned case study of unemployed men in USA as a prime example. Liebow 
had the opportunity to observe unemployed men in their day-to-day life and discover 
commonplace problems around the whole country. 
Conversely, a study of the same case at different points of time (two or more) may 
warrant a single-case research design. In this longitudinal case, it is possible to reveal 
how circumstances and conditions might have changed in the course of time and if there 
has been any progress or regress in relation to certain conditions. (Yin 2003, 42) 
However, a single-case study does not come without its caveats. Yin (2003, 42) 
states that before employing the single-case study method, it must be vigorously inves-
tigated in order to minimize the possibility that the case is misrepresentative and max-
imize the access to evidences. 
4.1.3 Multiple-case design 
Yin (2003, 46) states that across some fields of study, multiple-case design is seen as a 
separate methodology from single-case design altogether. Yin, however, considers them 
to be within the same methodological framework and thus variants of each other. As is 
evident from figure 9 and the definition, multiple-case design uses many cases within a 
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study. Multiple-case design can be seen as more rigorous and broad study due to the 
evidence consist of multiple cases.  In multiple-case design, every case should be care-
fully chosen as they should all serve a distinct purpose relative to the study and context. 
Again, Yin draws parallels with multiple experiments and multiple cases. 
As a rationale for multiple-case study design, Yin (2003, 52) concisely describes it 
“…derives directly from your understanding of literal and theoretical replications. The 
simplest multiple-case design would be a selection of two or more cases that are be-
lieved to be literal replications, such as a set of cases with exemplary outcomes in rela-
tion to some evaluation theory.” As described by Yin, the main rationale for using mul-
tiple-case study is replication. The replication logic either requires the cases to be cho-
sen in a way that it predicts opposing results but for foreseeable reason (a theoretical 
replication) or predicts the same outcome (a literal replication). Additionally, Yin em-
phasizes the importance of not confusing replication with sampling logic. 
As it is with a single-case design, multiple-case design is not without its downsides 
alike. Inherently, multiple-case design is more time and resource consuming than a sin-
gle-case design (Yin 2003, 47). In addition, it is easy for the researcher to lose sight of 
the uniformity of the study. 
4.1.4 Holistic vs embedded 
In regard to single-case design, the same case study can consist of more than one unit of 
analysis. This approach is called embedded case study in which within one case, also a 
subunit or subunits are taken into consideration. Yin (2003, 42) demonstrates an em-
bedded single-case with an example of a hospital, a single organization, where the re-
search incorporates results from multiple sources with various points of views within 
the organization. On the other hand, a holistic case study would analyze solely the gen-
eral or global characteristics of a project or an organization. The holistic design is better 
suited for cases without logical subunits and for situations where the fundamental theo-
ry central for the case is of holistic nature. The embedded design is oftentimes seen to 
be adding meaningful insights and extending the analysis to a more robust study.  
The multitude of cases in multiple-case design does not remove the holistic and em-
bedded variations. That is to say, a multiple-case study can be comprised of many em-
bedded cases or many holistic cases. 
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4.1.5 Embedded single-case study 
An embedded single-case study method will be chosen for the purpose of this study. 
As stated earlier, it is believed that Turku University hospital and its hospital pharmacy 
represent accurately the setup for all five University hospitals located in Finland. Hence, 
a case study is chosen. Furthermore, according to Yin (2003, 39-42), a single-case de-
sign is appropriate when the case is representative or typical. Thus, a single-case design 
will be used. Yin extends that an embedded single-case design may add significantly to 
a single-case study and therefore an embedded design will be utilized. 
4.2 Data collection and analysis 
Yin (2003, 83) identifies six different sources of evidence for case studies: direct obser-
vation, participant-observation, physical artifacts, documents, interviews and archival 
documents. Moreover, Yin (2003, 89) states that interviews are one of the most signifi-
cant sources of information in case studies.  
4.2.1 Interviews 
Interviews were selected to be the main method of data collection for this research. Ad-
ditionally, documents acquired from the interviewees were utilized to bolster the inter-
views. Data was collected through half-structured theme interviews with open-ended 
nature. The interviewees were pharmacists with differing job descriptions working in 
the hospital pharmacy in the University hospital of Turku. Pharmacists with different 
positions were chosen in order for the research to be more thorough. The job descrip-
tions for pharmacists interviewed included the head pharmacist, a pharmacist responsi-
ble for the information systems, a pharmacist responsible for logistics operation, and 
two pharmacists responsible for procurement. The two procurement pharmacists also 
had somewhat differing roles. One procurement pharmacist was mainly responsible for 
the preparation of the tendering process for suppliers and the other was more responsi-
ble for the operational day-to-day procurement process.  
The interviews started with a brief discussion of the responsibilities of each inter-
viewee and their background. Afterwards, a discussion was sparked with the goal of 
identifying areas in which medical waste was created within the upstream supply chain 
and procurement process. To guide the conversation towards this goal, a frame of six 
themes were discussed. The discussed themes were procurement process, pharmaceuti-
cal waste, expiration of pharmaceuticals, collaboration with suppliers, information sys-
44 
tems used in the procurement process and development initiatives. Each of these themes 
had a set of aiding questions, which are presented in appendix 1. The interviews took 
place in April and June of 2016. Summary of interviews is presented in table 4. 
Table 4 Summary of interviews 
Date Position Location 
20.4.2016 Head pharmacist Turku 
20.4.2016 Logistics pharmacist Turku 
20.4.2016 IT system pharmacist Turku 
2.6.2016 Procurement pharmacist Turku 
10.6.2016 Procurement pharmacist Turku 
 
The interviews were not recorded due to the lack of consent from interviewees and 
therefore notes were taken instead.  
4.2.2 Analysis of empirical data 
Yin (2003, 109) defines data analysis to be composed of categorizing, tabulating, com-
bining, testing and examining data. Yin extends that analysis of case study evidence is 
particularly challenging due to fact that analysis strategies and techniques relative to 
case studies have not been well outlined. The aim of analyzing the evidences is to ad-
dress the initial propositions of the study. 
In his study, Yin (2003, 111-115) proposes three main strategies for case study evi-
dence analysis. The main strategies are relying on theoretical propositions, developing 
case descriptions and setting up a framework based on rival expectations. Alongside the 
three main strategies, Yin (2003, 109) offers five analysis techniques to be used; time-
series analysis, logic models, cross-case synthesis, explanation building and pattern 
matching.  
This study will be employing the most commonly used analysis framework, the strat-
egy of relying on theoretical propositions. It indicates that the design and goals of the 
study are based on present propositions, which consequently correlate with the set of 
research questions, existing perception of the literature, and ultimately new propositions 
(Yin 2003, 112). The research framework created for this study (figure 8) will incorpo-
rate the previously discussed literature and the unique characteristics of the case study 
setting in attempt to discover answers to the research questions. 
For the purpose of this study, logic model -analysis method is chosen. A logic model 
seeks to describe intricate action sequences over time in a chronological, recurring, 
cause-effect-cause-effect pattern (Yin 2003, 127). In logic modelling, both empirically 
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noted events and theoretically anticipated events are combined and used (Yin 2003, 
127). Logic models can be seen as good ways of recognizing patterns within a process. 
The notes based on the interviews will be analyzed by creating a logic model of the up-
stream logistics process in attempt to identify the underlying reasons in the process 
which lead to medical waste. 
4.3 Reliability and validity 
For research design to be reliable and of high quality, it needs to provide answers to 
certain logical tests, which are built upon the concepts of credibility, confirmability, 
data dependability and trustworthiness. Yin (2003, 33-39) presents four different logical 
tests for quality assurance purposes: construct validity, internal- and external validity 
and reliablity.  
Construct validity represents the correct operational measures for the concepts of the 
study. Yin (2003, 35) recognizes this to be particularly problematic logical test in rela-
tion to case study research. Case studies are susceptible to the subjective judgement of 
the researcher in the data collection. This may be alleviated by using multiple sources of 
data, establishing the chain of evidence. Albeit this study is mainly constructed based on 
the interviews, also documents will be reviewed. Furthermore, multiple interviews are 
conducted in order to further enhance the construct validity of this study. Additionally, 
the chain of evidence will be established by producing the interview framework as well 
as the key findings and the analysis leading up to them.  
According to Yin (2003, 37) external validity refers to the ability of the case study to 
be generalized past that specific case. Single cases are often deemed to be insufficient 
for generalization purposes. However, frequently the critics mistakenly draw parallels 
with survey research, which depends on statistical generalization instead of theoretical 
generalization used in case studies. As stated previously, the conditions and circum-
stances apply similarly to all the University hospitals in Finland. Internal validity is not 
relevant in the context of this study as it is only applicable for causal studies.  
Reliability is presumably the most commonly acknowledged logical test. It aims to 
minimize the biases and flaws of a study. Essentially, a researcher should be able to 
replicate the exact same case study and come to the same conclusion in respect to the 
findings. The research framework and the interview frame have been documented and 
clearly described formerly to improve the reliability of this study.  
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4.4 Results 
In this section, the results of the research will be presented. First, the subject of the case 
study, Turku University hospital and its hospital pharmacy, will be briefly introduced. 
After this, the current procurement process will be described as well as the tools and 
information systems used in the process. This will be followed by an evaluation of the 
current process using the formulated framework detailed in figure 8. Finally, a proposal 
for a future procurement process will be presented and discussed. 
4.4.1 Turku University hospital and its hospital pharmacy 
Turku University hospital (TYKS) is one of five Finnish university hospitals, which 
offer specialized medical treatment. The other ones being located in Helsinki, Tampere, 
Oulu and Kuopio. According to reports from the Finnish National Institute of Health 
and Welfare, Turku University hospital is the second largest hospital in Finland meas-
ured by utilization, only after Helsinki university hospital (thl.fi, retrieved 2019). It is 
part of hospital district of Southwest Finland and provides health care services for some 
470 000 people in 28 municipalities (VSSHP.fi, retrieved 2019).  
At the end of 2017, Turku University hospital and its public utilities employed 1 020 
members of staff and during the fiscal year 2017 its operating expenses were 163,1 mil-
lion euros (3 % increase compared to year 2016). Out of the total operating expenses 
68,8 million euros or 42 % resulted from material purchases with an increase of 6,3 % 
to year 2016. Material expenditure in Turku University hospital echoes the notion made 
by Poulin (2003) that hospitals may spend on average 30 to 40 % in logistical activities 
of their overall operating costs. The largest share of the operating expenses by far comes 
from the medical service area’s pharmaceutical material purchases. In 2017, the phar-
maceutical material purchases accounted for 78 % of the total material purchases or 
53,9 million euros. Pharmaceutical material purchases have been in a steady ascent in 
the 2010s as can be seen from Figure 10. 
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Figure 10 Pharmaceutical material purchases 2009 – 2017 in Turku Univer-
sity hospital (VSSHP annual report 2017) 
The rising trend depicted in figure 10 clearly illustrates the need to examine and 
evaluate the current procurement processes and whether there are possibilities to im-
prove the process. 
Hospital pharmacy in Turku University hospital is responsible for supplying pharma-
ceuticals for all the departments within the entire hospital. Head pharmacist who over-
sees the organization and its operations leads the hospital pharmacy. Under the head 
pharmacist, there are licensed pharmacists each responsible for their own operational 
area. In total, the organization consist of 88 staff members of which roughly half are 
trained pharmacists. 
The hospital pharmacy operates in a two-echelon system where the hospital pharma-
cy alone is responsible for procurement of medicines for the whole hospital (LaPierre 
and Ruiz, 2007). A purchasing unit procures other materials. The pharmaceuticals are 
delivered to requesting departments using periodic replenishment model, which 
Lapierre and Ruiz (2007) suggest to be more suitable for health care organizations than 
models basing the replenishment on reorder point. It was commonly acknowledged 
within the hospital that the majority of the medical waste was created in the requesting 
departments. However, due to the lack of supporting information systems the medical 
waste was not reported and monitored accurately.  
The hospital pharmacy has two inventories. The larger, main inventory is managed 
by a state of the art inventory robot, which is capable of performing a full inventory 
check within three hours. The automatized inventory frees human resources for more 
demanding, pharmaceutical procedures, which can be seen as the most important ad-
vantage. Other benefits for the automated inventory management are reduction of hu-
man errors (while working correctly, practically error-free), itemization of products and 
traceability, uptime outside of regular working hours and efficient utilization of ware-
house space. It also has its limitations; the network of multiple information systems and 
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interfaces are more susceptible for malfunctions, there are surprisingly large number of 
packages that are unsuitable for the robot, electronic prescriptions contain many errors 
and the robot is not as flexible towards the customers as humans could be. The robot 
manages up to 90 large boxes filled with pharmaceutical packages a day of which still 
roughly 10 are unloaded and checked manually for quality assurance purposes. Current-
ly the automated inventory sustains some 70 000 packages (Interview with logistics 
pharmacist, 20.4.2016; documentation) 
The other warehouse is an open-shelfed over-the-night storage for abrupt medicine 
demands from the departments outside of working hours of the hospital pharmacy and 
during weekends. The over-the-night storage is not directly connected to any infor-
mation system and is still managed via an old-fashioned order book. Medical staff will 
submit their orders in the order book and independently collect the needed pharmaceuti-
cals from the open shelves. According to the logistics pharmacist (20.4.2016), a large 
portion of medical waste created within the hospital pharmacy is generated in the over-
the-night storage. Oftentimes, the medical staff are in a haste and order unnecessary 
items. Unused items should be returned to the storage and recorded in the order book 
but in reality, this does not happen frequently. (Interview with logistics pharmacist, 
20.4.2016; documentation) 
4.4.2 Current procurement process 
The current procurement process can be divided into two different sub-processes: bi-
annual tendering of pharmaceuticals and actual purchasing of pharmaceuticals. The ten-
dering process is basically an on-going process. When the tendering has been concluded 
for two-year period, the preparations for the next cycle begins. One of the most time-
consuming part of the tendering is maintaining the basic pharmaceutical offering. De-
cree 6/2012 by Finnish Medicine Agency (Fimea) stipulates that the basic pharmaceuti-
cal offering must guarantee safe, appropriate and economical medication. The basic 
pharmaceutical offering seeks to harmonize and direct the use and procurement of 
pharmaceuticals. The offering is guided by current national treatment practices and re-
lies fundamentally in scientific evidence. (Interview with head pharmacist, 20.4.2016; 
STM, 2018) 
The tendering process involves personnel from nearly all departments of the hospital 
pharmacy. It is extremely important to conduct the tendering with utmost care. For ex-
ample, the tendering period of 2016-2017 comprised of approximately 143 million eu-
ros worth of medicines and the tendering process was carried out in co-operation with 
four other hospital districts. The tender itself can contain up to 15 000 individual phar-
maceutical bids. Forecasting of the consumption is also key in the tendering process and 
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requires input and insight from professional pharmacists. The tendering process also 
contributes to medical waste. When the basic pharmaceutical offering changes due to 
the new contract period, some of the old medicines might be left unused. (Interview 
with head pharmacist, 20.4.2016; STM, 2018) 
In special circumstances, the hospital pharmacy may import special medicines inde-
pendently when those medicines are not available from the regular suppliers. In the need 
of independent importing, the logistics pharmacist will contact European wholesal-
ers/suppliers via email and order directly from them. However, the hospital pharmacy 
actively attempts to avoid independent importing. Furthermore, the hospital pharmacy 
will never initiate independent importing on cost basis. (Interviews)  
Three rotating procurement pharmacists manage the day-to-day purchasing process 
in two-week cycles. One reason mentioned for having three changing procurement 
pharmacists in charge of purchasing instead of just one dedicated, was the reluctance to 
take responsibility alone of the medical waste. Additionally, the rotation makes the 
work more diverse and pleasant. (Interview with IT pharmacist, 20.4.2016; interview 
with procurement pharmacist, 2.6.2016) 
Generally, the daily purchasing process begins with an alert and a purchasing sugges-
tion from the enterprise resource planning (ERP) system, webMarela. The system pre-
pares individual purchasing suggestions per supplier based on an alert point manually 
entered into the system and one procurement pharmacist reviews the list of medicines to 
be ordered. The purchasing suggestions may contain hundreds of lines. The interviews 
revealed that there were misconceptions within the organization about the amount of 
work resources tied up in the purchasing process. The logistics pharmacist was under 
the impression that only 10 % of suggested orders were reviewed manually when in 
reality, all the automatically suggested orders had to be reviewed one line at a time by 
the procurement pharmacists. Large portion of creating the order is based on the profes-
sional judgement of the pharmacist. Furthermore, orders with expiration date within six 
months of the delivery require additional approval. (Interview with IT pharmacist, 
20.4.2016; Interview with logistics pharmacist, 20.4.2016; interview with procurement 
pharmacist, 10.6.2016) 
After the review and possible changes made, the orders are confirmed. For the two 
largest suppliers, the orders can be directly made in webMarela via integrated interface. 
For the third, smaller, main supplier, the order needs to be made first in supplier’s web 
portal and then again in webMarela, essentially doubling the workload. For the smaller 
suppliers, the orders are placed via email. Afterwards, an order confirmation is received 
from the suppliers and the orders are usually fulfilled with one to two days of lead-time. 
Figure 11 portrays the current procurement process on a high level and systems and 
interfaces between parties. (Interview with IT pharmacist, 20.4.2016; interview with 
procurement pharmacist, 10.6.2016) 
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Figure 11 Purchasing process and information system interfaces 
4.4.3 Information systems in hospital pharmacy 
The main information system used in the hospital pharmacy is its ERP, webMarela. It is 
used for inventory management, ordering, receiving and provisioning. As it was first 
implemented some ten years ago, it can be seen as a relatively old system. However, it 
is developed and updated continuously to improve the reliability and functionality of the 
system. In the hospital pharmacy, there is an IT pharmacist responsible for the mainte-
nance and development of the system. IT pharmacist also works as an intermediary be-
tween the hospital pharmacy and the system service provider and offers immediate sup-
port for other pharmacists using the system. (Interview with IT pharmacist 20.4.2016) 
WebMarela is also used in the requesting departments. However, it is used through 
separate OSTI-module. As shown in figure 11, the requesting departments are able to 
see the stock balance of each pharmaceutical item from OSTI. The problems concerning 
medical waste arise from the fact that the requesting departments are not able to see the 
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expiration details of each medicine. This creates information asymmetry and the re-
questing departments may order large quantities of medicines with short expiry dates. 
The hospital pharmacy has tried to remedy this problem with the employment of trained 
pharmacists at the requesting departments. These department pharmacists have access to 
the regular interface of webMarela and thus are able to see the expiration dates of medi-
cines. The results in reducing medical waste and unnecessary orders have been promis-
ing albeit expensive. All orders placed by the requesting departments are visible in the 
stock balances in real-time. (Interview with IT pharmacist, 20.4.2016; interview with 
procurement pharmacist, 10.6.2016) 
WebMarela has integrated interfaces with the two largest suppliers, which constitute 
over 95 % of the placed orders. The orders can be directly placed within the system and 
the order confirmation is received automatically in webMarela. In webMarela, the pro-
curement pharmacists are able to see the stock balances and the expiry dates of the med-
icines. However, if an individual item is stored in two separate warehouse locations, the 
system only shows the expiry of just the other. This again creates information asym-
metry and the hospital pharmacists may order products with the assumption of long ex-
piry dates. In these circumstances, the supplier has incentive to ship the goods with 
shorter expiry dates, which again leads to unnecessary returns. An important develop-
ment initiative that arose from the interviews was the ability to see the expiry dates of 
all the supplier’s warehouse locations. In conjunction with that, also an upgrade in OSTI 
to be able to see the expiry dates in hospital pharmacy was high on the list of develop-
ment ideas. (Interview with IT pharmacist, 20.4.2016; interview with procurement 
pharmacist, 10.6.2016) 
As can be seen from figure 11, the third largest supplier does not have an integrated 
interface with webMarela and the orders need to be double-booked first in webMarela 
and then in the supplier’s web portal. According to the interviews, there would be need 
for integration since this would reduce the workload and make the process less time 
consuming. The amount of orders placed to the smaller suppliers is negligible and there 
was a consensus among the interviewees that there is no need for integration for smaller 
suppliers. (Interview with procurement pharmacist, 10.6.2016) 
The interviewees were of an opinion that the functionality and usability of webMa-
rela were on a good level. Nonetheless, the aforementioned development initiatives in 
system integrations were emphasized. The development of the system is performed in 
collaboration with the system service provider and the initiatives are communicated by 
the IT pharmacist. In the IT pharmacist’s view, the hospital pharmacy lacked the re-
sources and required knowledge in order for the development to be swifter. Further-
more, in the event of a version upgrade, the IT pharmacist felt that the hospital pharma-
cy had inadequate resources for the testing. The interviews also revealed that occasion-
ally the system can be slow and unstable due to the constraints in IT infrastructure. 
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However, this was not seen as a huge hindrance regarding the procurement process. If 
webMarela was down, the procurement pharmacists have always the option to make the 
needed orders directly in the supplier’s web portal. This was considered a good fail-
safe. (Interview with IT pharmacist, 20.4.2016; interview with procurement pharmacist, 
10.6.2016) 
A sub-optimal use of webMarela’s functionalities was exposed during the interviews. 
This was acknowledged by the IT pharmacist but it was also recognized that more op-
timal use would require better know-how and resources. The sub-optimal use of web-
Marela was the most evident in the system parametrization of the medical items, espe-
cially regarding the alerts, which initiate order suggestions. Currently, in most cases, the 
suggested orders need to be altered by the procurement pharmacist. This could be reme-
died by better parametrization. It needs to be noted that going through all the parameters 
for all the items is a massive effort but even the re-parametrization on the item group 
level could improve the situation by a large margin. (Interview with IT pharmacist, 
20.4.2016; interview with procurement pharmacist, 10.6.2016) 
4.4.4 Medical waste in the hospital pharmacy 
It was generally accepted, even by the requesting departments themselves, that most of 
the medical waste was created in the requesting departments (Interview with head 
pharmacist, 20.4.2016; Peltoniemi, 2019). This can also be seen from the figure 12. 
However, the upstream logistics process also creates substantial medical waste. The 
main reason for this, the mandatory reserve supplies, was echoed by reports and inter-
views alike (Interview with procurement pharmacist, 2.6.2016; STM report, 2018).  
 
 
Figure 12 Medical waste in TYKS (Peltoniemi, 2019) 
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The red line lowest in figure 12 is indicative of the rising trend in medical waste that 
needs attention. Other noted contributing factors were the over-the-night warehouse, 
ordering habits of the requesting departments and constraints in the information system 
integrations to suppliers. As mentioned earlier, the over-the-night warehouse and its 
old-fashioned and informal order booking method enables medical waste creation. The 
ordering process for the requesting departments is expensive and time consuming and 
thus they order large quantities in longer intervals. This in turn makes the forecasting of 
the total consumption harder and more complex. Although the information systems 
have relatively high level of integration, there is still room for improvement. WebMa-
rela does not show the expiry information for all the suppliers’ warehouses and occa-
sionally the ordered pharmaceuticals might have shorter expiry dates than initially sup-
posed. This creates a hard decision concerning returning the products; the medicines 
might be needed immediately but a large portion of it might go to waste due to the short 
expiration. (Interviews with procurement pharmacists, 2.6.2016 and 10.6.2016) 
Due to the constraints of the mandatory reserve supplies, it is practically impossible 
to reduce the medical waste entirely but an attempt has to be made. Next, we will be 
looking into the possibility to battle medical waste within the upstream logistics process 
using a framework formulated in this research. The purpose of the framework is to 
evaluate the suitability of collaborative VMI arrangements in the context of Finnish 
hospital pharmacy. The framework consists of six contingent factors: supply chain net-
works’ relational structure, regulatory environment, spatial complexity, goal congru-
ence, product characteristics and physical characteristics. We will be discussing each of 
these in more detail. 
4.4.5 Supply chain network’s relational structure 
In the case of hospital pharmacy and its pharmaceutical wholesalers, the supply chain 
network’s relational structure can be construed as simple. There are only three large 
suppliers of which two constitute over 95 % of the volume. This would enable the hos-
pital pharmacy to engage in collaborative VMI arrangements easier as the collabora-
tions have only few participants. Furthermore, the single-channel system increasingly 
simplifies the collaborations, as there would be no need for the competing wholesalers 
to collaborate. Only one specific pharmaceutical can be ordered from one wholesaler 
and thus the only collaboration required would be between the hospital pharmacy and 
the wholesaler in question. 
As stated by Danese (2007), the level of existing supply chain integrations has an ef-
fect on the collaborations. In this case, the integration can be seen to be on a relatively 
high level. There is already existing information system integration between the two 
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largest suppliers and the hospital pharmacy. This exhibits the capability of parties in 
entering into more collaborative arrangements and further developing the information 
system integrations. Currently, the information system integrations are only one-way, as 
the suppliers do not have access to the information generated in webMarela. A prerequi-
site for collaborative VMI arrangements would be a two-way information system inte-
gration. The suppliers would need the access to the information regarding the stock bal-
ances in the hospital pharmacy’s inventory and regarding the actual consumption of the 
medicines. Consequently, the suppliers would be able to adjust their deliveries based on 
the actual stock levels and well-formulated demand forecasts. 
At present, the other form of integration and collaboration between the suppliers and 
the hospital pharmacy is rather limited. The parties convene only once a year to discuss 
development and assess the as-is situation. Otherwise, the communication extends only 
to email exchange and occasional feedback questionnaires from the suppliers.  Willing-
ness to increase the level of collaboration emerged from the interviews. (Interviews) 
4.4.6 Regulatory environment 
The regulatory environment creates multiple challenges for collaborative VMI arrange-
ments. Bhakoo et al (2012) concluded that in highly regulatory settings, it is better for 
the partners in supply chain to manage inventories using internal control methods. As 
has been presented earlier, the pharmaceutical industry in Finland is highly regulated. 
Additionally, there are multiple legislative requirements for the hospital pharmacies, 
which further complicates the state of affairs. For example, the Decree on medicines 
(1987/693) outlines the responsibilities and requirements for hospital pharmacies and 
the medicine law (1987/395) gives the broader guidelines regarding medical supply and 
manufacturing (fimea.fi). Furthermore, the mandatory reserve supplies creates a seem-
ingly insurmountable obstacle regarding medical waste. However, the fact that the man-
datory reserve supplies also extends to the wholesalers, reduce the negative effect on 
collaborative VMI arrangements. 
Again, the single-channel system can be seen as creating a beneficial regulatory envi-
ronment for the collaborative VMI arrangement to succeed. It allows for more simple 
and straightforward collaborations. The rigid system with high entry barrier also ensures 
that the collaborations can be projected long to the future. However, it also requires to 
be acknowledged that the single-channel system is not without its flaws. This was evi-
dent from the failed ERP implementation at one of the larger suppliers which caused 
extensive problems in medical supply across the country. 
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4.4.7 Spatial complexity 
Spatial complexity has an effect on the possibility to enter into collaborative VMI ar-
rangements. If the spatial complexity is low, collaborative VMI arrangements are more 
viable option. Turku University hospital pharmacy is located in southwest Finland some 
150 kilometers from Finnish capital, Helsinki. According to the report prepared for the 
Finnish social- and health ministry, the branches of pharmaceutical wholesalers are 
mainly located in the southern Finland (STM, 2018). Hence, the spatial complexity be-
tween the parties involved in the collaboration would be low. Bhakoo et al. (2012) de-
termined that a supply chain partner with low spatial complexity is able to utilize col-
laborative arrangements as an inventory management method.  
Although the spatial complexity in this specific instance is low, it should be noted 
that, in general, Finland is a country of long distances. This concern was also brought 
up in the report prepared for Finnish social- and health ministry (STM, 2018). 
The low spatial complexity allows for more frequent deliveries and thus requires 
smaller inventory space in the hospital pharmacy. The shorter transport distances also 
increase the reliability of the cold chain for pharmaceuticals requiring it and thus reduce 
the medical waste generated in the instance of broken cold chain.  
4.4.8 Goal congruence 
Danese (2007) concluded that the goals of collaboration determine the level of collabo-
ration. If the goal is efficiency, the level of collaboration is often limited to data ex-
change. If the objective is to improve responsiveness, the likelihood of deeper collabo-
ration is higher. Bhakoo et al. (2012) elaborate that the degree of commitment and trust 
between supply chain partners is indicative of the chances of the parties entering into 
collaborative arrangements. 
Although efficiency can always be seen as an important goal in supply chain man-
agement, the mandatory reserve supplies will always limit the efficiency aspect of med-
ical supply in hospital pharmacies. Thus, it would be beneficial for both the suppliers 
and hospital pharmacy to allocate their resources into improving responsiveness. Col-
laborative VMI arrangements would be a great tool to achieve this.  
Ombaka (2009) noted that it is paramount within hospital supply chains to deliver 
medicines in the right places, at the right time and in correct quantities.  A collaborative 
VMI arrangement where the wholesaler would handle the supply of pharmaceuticals in 
conjunction with collaborative forecasts could be a potential remedy for generation of 
unnecessary medical waste. For example, the wholesaler would have better knowledge 
of lead-times between its warehouses and thus, would be able to better design the re-
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plenishment patterns. This would eliminate the problem of not receiving medicines with 
the wished expiration dates. Lin and Ho (2014) summarized the benefits of collabora-
tive arrangements shown in table 3. Reflecting the interviews with the benefits, reduc-
tion in shortages, creation of urgent orders and the time relieved from the purchasing 
activities were seen as key benefits.  
For the suppliers to enter in such collaborative arrangements there should also be in-
centives and benefits for them. Currently, the agreements allow the hospital pharmacy 
to return deliveries for products with bad expiry dates (Interviews). This ties up re-
sources and creates logistics costs for the supplier. The wholesalers would have innate 
incentive to reduce logistics costs and deliver products with preferable expiry dates.  
Other tangible benefits for the wholesalers would be the potential reduction in deliv-
eries. As the wholesaler would have the whole picture of the total demand and the in-
ventory balances, they would be potentially able to better answer the demand with fewer 
deliveries.  
Bhakoo et al. (2012) noted in their research that hospitals were reluctant to relinquish 
the control over pharmaceutical procurement. They stressed the paramount importance 
of trust between supply chain partners. Trust, in business relationships in particular, is 
built during the course of a longer period. The long history of association with the sup-
pliers in Finland permits for good trust and the interviews strengthen this evaluation. 
4.4.9 Product characteristics 
Both Danese (2007) and Bhakoo et al. (2012) state that product characteristics have an 
impact on collaborative VMI arrangements. Danese (2007) notes that items with high 
demand and supply elasticity are more likely to be included in collaborative VMI ar-
rangements. Bhakoo et al. (2012) extend the interpretation in hospital environments to 
functional and innovative products. The interviews revealed that many of the products 
in the basic pharmaceutical offering have fairly constant demand and thus the consump-
tion is more easily forecasted. 
The collaboration in forecasting is also important for products with high seasonality. 
For instance, flu vaccinations are required mostly during the flu season but the timing of 
the flu season can vary. The wholesalers might not have the best information available 
and thus they would need to collaborate with medical professionals to formulate an ac-
curate forecast.  
The interviews revealed that some pharmaceutical groups are more vulnerable for 
medical waste than others are. Medicines, which can be placed in the ‘innovative’ -
category (Bhakoo et al., 2012) were more prone to generate medical waste than the 
medicines in the ‘functional’ –category. Furthermore, the innovative medicines also 
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have an inclination to be more expensive than the functional medicines. The collabora-
tive VMI arrangements could be implemented on a pharmaceutical group basis. If the 
hospital pharmacy is not comfortable to relieve all control over the whole pharmaceuti-
cal offering, a possible solution could be to choose specific groups under the supplier’s 
control. It would also be reasonable to pilot the VMI arrangement with one pharmaceu-
tical group before embarking in a full collaborative VMI arrangement. 
Products requiring cool storage and uninterrupted logistical cold chain create prob-
lems in the current upstream logistical process. One procurement pharmacist noted that 
at present, they were not able to order cold products on Mondays, which in turn creates 
a huge spike in logistics on Tuesdays. This spike in logistics could be resolved by using 
collaborative VMI arrangements. The supplier would be able to see the stock balances 
in real-time and supply cold products on Mondays accordingly. (Interviews) 
4.4.10 Physical characteristics 
Physical attributes such as availability of warehouse area, stage of IT adaptation and the 
size of the health care organization are all drivers that factor in the possibility to enter 
into collaborative VMI programs (Bhakoo et al., 2012). Larger hospitals are able to take 
advantage of economies of scale. Furthermore, larger hospitals generally have bigger 
storage facilities, which enables the supply chain partners for more flexible inventory 
management. The IT adaptation is also a prominent factor in collaborative VMI ar-
rangements as formerly described. 
Turku University hospital can be interpreted to tick all the boxes in physical charac-
teristics that support collaborative VMI arrangements. The hospital pharmacy has im-
plemented an inventory robot, which can independently receive and store pharmaceuti-
cal products. The possibility of round-the-clock receiving allows the suppliers to do 
more flexible deliveries. Additionally, it is integrated with the hospital pharmacy’s ERP 
and automatically shows the stock balances of items in real-time and it is able to receive 
products at any given time. Furthermore, the IT adaptation can be determined to be on 
good level considering the interfaces with suppliers and the inventory robot. In the mid-
2010s, the hospital pharmacy relocated to brand new facilities with ample storage space. 
The inventory robot also permits for better inventory space utilization than a regular 
shelf-storage.  
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5 DISCUSSION AND CONCLUSIONS 
It has been established that medical waste in pharmaceuticals is a problem on a nation-
wide scale in Finland and moreover, globally. The increasing trend in pharmaceutical 
purchases indicate that the problem will only grow unless a cure to minimize the waste  
can be found. This section will lay out the summary of findings and discuss the re-
search. 
5.1 Summary of findings 
This research set out to explore pain points that generate medical waste in the upstream 
logistics process and possible solutions for them. The goal of this thesis was to answer 
three questions; what are the best practices in medical supply chain management, what 
is the current state of pharmaceutical procurement processes and information systems in 
Turku University hospital and what are the future prospects of integration in hospital 
procurement processes and information systems? The interview results were analyzed in 
regard to the research framework formulated based on the literature reviewed.  
The study revealed that a collaborative VMI arrangement with pharmaceutical sup-
pliers could be a possible solution in battling the medical waste in upstream logistics 
process in hospital pharmacies. The unique characteristics of Finnish pharmaceutical 
industry both enable and complicate the implementation of VMI programs. On the other 
hand, the mandatory reserve supplies creates inevitable medical waste while at the same 
time, the single-channel system can be seen as an excellent fit towards VMI programs. 
The single-channel system creates a simplified supply chain -network structure where 
specific pharmaceutical products may be procured only from a certain wholesaler. The 
fact that there are only three larger pharmaceutical wholesalers in Finland creates an 
even more advantageous supply chain -network structure. The already existing integra-
tion of IT systems with the two largest pharmaceutical wholesalers further bolsters the 
case for collaborative VMI arrangements.  
It was also evident from the research that the spatial complexity in the case of Turku 
University hospital is low, which in turn permits VMI programs. Moreover, both the 
suppliers and hospital pharmacy would benefit from a collaborative VMI program as 
their goals would be aligned and thus the possibility of success in collaboration would 
increase. The physical characteristics of Turku University hospital are also suitable for 
VMI arrangements. 
The current procurement process in the Turku University hospital is manual and re-
source consuming. A collaborative VMI arrangement would relieve the pharmacists 
from the labor extensive manual procurement process and enable them to concentrate on 
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tasks requiring more medical expertise. WebMarela, the ERP used in the hospital phar-
macy, is seen as a well-functioning information system, although improvements could 
be made. Information visibility in the system throughout the whole supply chain could 
be increased and the integrations to suppliers could be made two-way. Currently the 
wholesalers do not have visibility to stock levels or demand in webMarela. This is also 
a requirement for collaborative VMI program. 
5.2 Discussion 
The on-going social security and health care reform has been a hot topic for the past 
decade and mostly not in a positive light. Furthermore, the infamous Apotti –venture 
has added to the discussions and has received plenty of criticism both from the academ-
ics and the taxpayers. This shows that there is still a lot of room for improvement in the 
health care industry. There seems to be a consensus that the health care sector lags be-
hind other industries in IT adaptation and application of best practices in supply chain 
management (Chen et al, 2013; de Vries and Huijsman, 2011). Although the root cause 
for medical waste within the upstream supply chain in hospital pharmacies cannot be 
entirely attributed to the lack of IT adaptation and best practices, improving these might 
help in the battle against medical waste.  
This study reinforces the notion that the procurement processes and IT systems in-
volved in the process could be developed further. Currently, the procurement process 
for pharmaceuticals appears to be manual and labor extensive. The interviews revealed 
that there were misconceptions about the procurement process even within a small or-
ganization in the hospital pharmacy. Additionally, the procurement pharmacists were 
not able to view the expiration dates for the pharmaceutical products in all the ware-
houses at the wholesalers, which in turn resulted in either bad expiry medicines or re-
turns. Neither of these options is good for the efficiency in the supply chain or medical 
waste. 
It has to be acknowledged that the reduction in medical waste is not an easy task by 
any means, especially in the upstream logistics processes. The mandatory reserve sup-
ply will inevitably result in medical waste. However, there are possibilities to improve 
the current processes and information systems and through that eliminate unnecessary 
medical waste. 
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5.3 Limitations and future research suggestions 
When reading through this study and interpreting its results, it is necessary to under-
stand that there are also limitations to this study. First, this study was performed from 
the point of view of the hospital pharmacy without consideration to the point of view of 
the pharmaceutical wholesalers. Interviews with the other participants in the collabora-
tive VMI program would have given a more comprehensive and pragmatic overview. 
The pharmaceutical wholesalers might have different ideas and views on the problems 
within the processes. 
Furthermore, the study was conducted as a single-case study, which has its own limi-
tations. A multiple-case study with other university hospitals could have been em-
ployed. Again, this would have given a broader view of the problems and possible solu-
tions to them. 
For future research to build on this research, it would be interesting to include the 
supplier aspect in the equation. Moreover, it would be interesting to perform a study on 
medical waste as a quantitative instead of qualitative. This could strengthen or disprove 
the conception that the pharmaceutical staff has regarding the medical waste and its 
origins. One additional future research possibility would be to extend the research to a 
similar university hospital in Sweden as they have equivalent single-channel system in 
pharmaceuticals. 
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APPENDIX 1 
Theme interview: 
 1) Procurement process 
• What triggers an order? 
• What defines the quantity of the order? 
• Are there differences in the procurement process between suppliers? 2) Pharmaceutical waste 
• In what part of the supply chain the medical waste is thought to be gen-erated?  
• Is procurement process involved in the generation of medical waste?  3) Expiration of pharmaceuticals  
• How accurate are the pharmaceutical expiration information in suppliers’ systems?  
• How often the ordered expiration dates match with received expiration dates of products?  4) Collaboration with suppliers 
• Is there any collaboration? 
• What kind of collaboration? 
• Should the collaboration be further developer and how? 5) Information system used in the procurement process 
• Functionality? 
• Integrations to suppliers’ systems? 6) Development initiatives 
• Development ideas for the system? 
• Additional functionalities? 
• Development ideas for the process? 
 
 
 
 
 
 
